Outcome of patients with known metastatic gastric cancer undergoing resection with therapeutic intent

Annals of Surgical Oncology

Volumn 14, Issue 2, 2007, Pages 365-372

  Gold, Jason S ^a   Jaques, David P ^a   Bentrem, David J ^a   Shah, Manish A ^a   Tang, Laura H ^a   Brennan, Murray F ^a   Coit, Daniel G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chemotherapy; Cytology; Gastric cancer; Metastatic; Resection; Surgery

Indexed keywords

CAPECITABINE; CISPLATIN; DOCETAXEL; DOXORUBICIN; FLOXURIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; METHOTREXATE; PACLITAXEL;

ABDOMINAL ABSCESS; ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CYTOLOGY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GASTRECTOMY; HUMAN; INFECTION COMPLICATION; LAPAROSCOPY; LENGTH OF STAY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVARY METASTASIS; PATIENT SELECTION; PERITONEUM METASTASIS; PLEURA EFFUSION; PREOPERATIVE TREATMENT; PROGNOSIS; PROSPECTIVE STUDY; STOMACH CANCER; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; VISCERAL METASTASIS; WOUND DEHISCENCE; WOUND INFECTION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 33846585490     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-006-9059-z     Document Type: Article

References (23)

1. In: Ries LAG, Eisner MP, Kosary CL (edset al. SEER Cancer Statistics Review, 1975-2002 Bethesda, MD: National Cancer Institute; 2005.
2. Burke EC, Karpeh MS, Conlon KC, Brennan MF. Laparoscopy in the management of gastric adenocarcinoma. Ann Surg 1997; 225(3):262-7.
3. Bentrem DJ, Wilton A, Mazumdar M, et al. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol 2005; 12(5):347-53.
4. Hundahl SA, Menck HR, Mansour EG, Winchester DP. The National Cancer Data Base report on gastric carcinoma. Cancer 1997; 80(12):2333-41.
5. Sarela AI, Miner TJ, Karpeh MS, et al. Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma. Ann Surg 2005; 243(2):189-195.
6. Hartgrink HH, Putter H, Klein Kranenbarg E, et al. Value of palliative resection in gastric cancer. Br J Surg 2002; 89(11):1438-43.
7. Stomach. (2002) In: AJCC Cancer Staging Manual, Sixth Edition. New York: Springer Science and Business Media, Inc., pp 99-106.
8. Burke EC, Karpeh MS Jr, Conlon KC, Brennan MF. Peritoneal lavage cytology in gastric cancer: an independent predictor of outcome. Ann Surg Oncol 1998; 5(5):411-5.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-62.
10. Sugarbaker PH, Yonemura Y. Palliation with a glimmer of hope: management of resectable gastric cancer with peritoneal carcinomatosis. Hepatogastroenterology 2001; 48(41):1238-47.
11. Haugstvedt T, Viste A, Eide GE, Soreide O. The survival benefit of resection in patients with advanced stomach cancer: the Norwegian multicenter experience. Norwegian Stomach Cancer Trial. World J Surg 1989; 13(5):617-21.
12. Maekawa S, Saku M, Maehara Y, et al. Surgical treatment for advanced gastric cancer. Hepatogastroenterology 1996; 43(7):178-86.
13. Kikuchi S, Arai Y, Morise M, et al. Gastric cancer with metastases to the distant peritoneum: a 20-year surgical experience. Hepatogastroenterology 1998; 45(22):1183-8.
14. Kikuchi S, Tsukamoto H, Mieno H, et al. Results of resection of gastric cancer with distant metastases. Hepatogastroenterology 1998; 45(20):592-6.
15. Inada T, Ogata Y, Kubota T, et al. D2-lymphadenectomy improves the survival of patients with peritoneal cytology-positive gastric cancer. Anticancer Res 2002; 22(1A):291-4.
16. Kunisaki C, Shimada H, Akiyama H, et al. Survival benefit of palliative gastrectomy in advanced incurable gastric cancer. Anticancer Res 2003; 23(2C):1853-8.
17. Yoshikawa T, Kanari M, Tsuburaya A, et al. Should gastric cancer with peritoneal metastasis be treated surgically? Hepatogastroenterology 2003; 50(53):1712-5.
18. Moriwaki Y, Kunisaki C, Kobayashi S, et al. Does the surgical stress associated with palliative resection for patients with incurable gastric cancer with distant metastasis shorten their survival?. Hepatogastroenterology 2004; 51(57):872-5.
19. van der Burg ME, van Lent M, Buyse M, et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med 1995; 332(10):629-34.
20. Fujimoto S, Takahashi M, Mutou T, et al. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 1997; 79(5):884-91.
21. Glehen O, Schreiber V, Cotte E, et al. Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg 2004; 139(1):20-6.
22. Hall JJ, Loggie BW, Shen P, et al. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer. J Gastrointest Surg 2004; 8(4):454-63.
23. Yonemura Y, Kawamura T, Bandou E, et al. Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 2005; 92(3):370-5.